HLA-C and cancer: These antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells, e.g., dendritic cells, can be recognised by T cells to trigger cytotoxic activity against cancer cells, in the process known as cancer surveillance (Zhang et al. 2017).